Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI)

CUSIP: 46116X101

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, $0.0001 Par Value Per Share
Shares outstanding
107,800,271
Total 13F shares
80,764,803
Share change
+11,810,602
Total reported value
$4,938,561,645
Put/Call ratio
56%
Price per share
$61.19
Number of holders
233
Value change
+$733,231,750
Number of buys
147
Number of sells
91

Quarterly Holders Quick Answers

What is CUSIP 46116X101?
CUSIP 46116X101 identifies ITCI - Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) as of Q1 2022

As of 31 Mar 2022, Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) was held by 233 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 80,764,803 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, WASATCH ADVISORS INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Bellevue Group AG, MARSHALL WACE, LLP, LORD, ABBETT & CO. LLC, STATE STREET CORP, and FRANKLIN RESOURCES INC. This page lists 233 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.